Avricore Health (AVCRF) Non-Current Debt (2022)

Avricore Health (AVCRF) posted quarterly Non-Current Debt of $29468.1 for Q4 2022.

Avricore Health (AVCRF) Non-Current Debt (2022) Analysis & Trends

Avricore Health (AVCRF) has reported Non-Current Debt for 1 consecutive years, with $29468.1 the latest figure, recorded in Q4 2022.

  • In Q4 2022, Non-Current Debt changed N/A year-over-year to $29468.1; the TTM figure through Dec 2022 stood at $29468.1 (changed N/A YoY), while the FY2022 annual figure was $30766.6, changed N/A from the prior year.
  • Non-Current Debt held at $29468.1 in Q4 2022 per AVCRF's latest filing.
  • Across five years, Non-Current Debt topped out at $29468.1 in Q4 2022 and bottomed at $29468.1 in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Thermo Fisher Scientific 213.40 Bn 209.33 Bn 8.34 Bn 42.28 Bn
2 Danaher 139.94 Bn 135.59 Bn 3.61 Bn 25.15 Bn
3 Idexx Laboratories 46.03 Bn 45.83 Bn 779.09 Mn 299.87 Mn
4 Agilent Technologies 39.69 Bn 37.88 Bn 990.00 Mn 3.05 Bn
5 Iqvia Holdings 39.32 Bn 37.24 Bn 1.44 Bn 13.71 Bn
6 Natera 38.47 Bn 37.37 Bn 696.04 Mn -
7 Illumina 29.98 Bn 28.82 Bn 770.00 Mn 1.49 Bn
8 Mettler Toledo International 28.57 Bn 28.52 Bn 650.22 Mn 2.04 Bn
9 Quest Diagnostics 26.21 Bn 25.58 Bn 1.03 Bn 5.64 Bn
10 Avricore Health 3.04 Mn 3.01 Mn -6,202.70 -

Historic Data

Download Data
DateValue
Dec 31, 2022 29,468.12